(Q44443467)

3 December 2017

title

Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia (English)

1 reference

3 December 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2402862

3 January 2024

4

Y. Shen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

author name string

M. B. Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

C. Koller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

Y. Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

S. O'Brien

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

H. Kantarjian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

J. Davis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

E. Estey

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750721

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12750721

3 January 2024

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://www.nature.com/articles/2402862.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.LEU.2402862

https://www.nature.com/articles/2402862

3 January 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.LEU.2402862

3 January 2024

1 reference

3 December 2017

volume

17

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

990-993

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402862

3 December 2017

exact match

0 references

cites work

Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402862

Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402862

Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402862

FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402862

inferred from DOI database lookup

7 January 2021

based on heuristic

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402862

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without gran

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402862

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

1043959383

0 references

1 reference